Clinic
Public Hospital District 3 of Pacific County
Public Hospital District 3 of Pacific County was paid $11.29M by Medicaid between Jan 2018 and Dec 2024, across 106 billing codes. Its largest line is 99283, emergency room visit (moderate) — 12% of everything it billed.
33Billing provider infoPUBLIC HOSPITAL DISTRICT 3 OF PACIFIC COUNTY
ILWACO, WA 98624
ILWACO, WA 98624
33aNPI1295771376assigned 06/20/2006
33bProvider typeCritical Access Hospital Clinic/Center
28Total paid$11.29M
24GClaims164,619
24DCodes billed106
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 25,265 | $2.02M | |
| 2019 | 29,034 | $1.48M | |
| 2020 | 19,855 | $989K | |
| 2021 | 26,623 | $1.52M | |
| 2022 | 26,438 | $2.28M | |
| 2023 | 22,804 | $1.81M | |
| 2024incomplete | 14,600 | $1.20M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 12% | 17,106 | 14,542 | $1.38M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 12% | 10,490 | 8,164 | $1.35M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 7.6% | 4,079 | 2,960 | $859K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 7.6% | 479 | 458 | $858K |
| 80053 | Comprehensive metabolic panel | 5.0% | 11,978 | 10,418 | $570K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 4.7% | 6,879 | 2,878 | $533K |
| 70450 | Computed tomography, head or brain; without contrast material | 4.0% | 730 | 694 | $457K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.9% | 4,181 | 3,655 | $439K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.6% | 11,389 | 9,620 | $405K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3.0% | 232 | 219 | $340K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.7% | 3,383 | 2,888 | $301K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2.5% | 3,191 | 2,684 | $287K |
94 more codes
| 71045 | Radiologic examination, chest; single view | 2.3% | 2,685 | $258K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.1% | 1,791 | $234K |
| 80061 | Lipid panel | 1.7% | 3,279 | $198K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.6% | 3,040 | $176K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.4% | 2,598 | $160K |
| 84484 | 1.4% | 3,445 | $153K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.3% | 2,058 | $152K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.2% | 1,391 | $137K |
| 36415 | Collection of venous blood by venipuncture | 1.2% | 15,250 | $134K |
| 71046 | Radiologic examination, chest; 2 views | 1.1% | 1,178 | $123K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.0% | 2,711 | $115K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 2,575 | $109K |
| 81001 | <1% | 5,037 | $104K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,748 | $92K |
| 83690 | <1% | 2,010 | $91K | |
| 80306 | <1% | 839 | $84K | |
| 83735 | <1% | 3,471 | $80K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 305 | $66K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 944 | $62K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 1,028 | $60K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,598 | $59K |
| 83605 | <1% | 1,718 | $59K | |
| 83880 | <1% | 1,255 | $51K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,117 | $47K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 3,131 | $47K |
| 80050 | General health panel | <1% | 231 | $43K |
| 96376 | <1% | 574 | $37K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 693 | $37K |
| 97162 | <1% | 331 | $33K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 294 | $32K |
| 81025 | <1% | 913 | $31K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 365 | $31K |
| 85610 | <1% | 1,728 | $27K | |
| 87040 | <1% | 536 | $24K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 494 | $22K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,061 | $20K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 14 | $19K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 873 | $18K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,444 | $17K |
| 85379 | <1% | 341 | $16K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 421 | $15K |
| 85027 | <1% | 529 | $15K | |
| 84439 | <1% | 284 | $13K | |
| 87186 | <1% | 269 | $13K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 221 | $13K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 13 | $13K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 1,400 | $12K |
| 97161 | <1% | 173 | $12K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 106 | $11K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 385 | $11K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 1,171 | $11K |
| A4649 | Surgical supply; miscellaneous | <1% | 60 | $10K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 237 | $8K |
| 86803 | <1% | 172 | $7K | |
| 73030 | <1% | 56 | $7K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 66 | $7K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 366 | $6K |
| 72100 | <1% | 40 | $6K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 480 | $6K |
| 73562 | <1% | 42 | $6K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 244 | $5K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 48 | $5K |
| 73610 | <1% | 29 | $4K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 349 | $4K |
| J2704 | Injection, propofol, 10 mg | <1% | 181 | $4K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 39 | $3K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 1,595 | $3K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 517 | $3K |
| 73630 | <1% | 24 | $2K | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 88 | $2K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 159 | $2K |
| 73502 | <1% | 15 | $2K | |
| 76641 | <1% | 14 | $2K | |
| 84481 | <1% | 26 | $2K | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 120 | $2K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 119 | $1K |
| 82077 | <1% | 27 | $1K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 97 | $1K |
| 82728 | <1% | 12 | $709.81 | |
| 87070 | <1% | 12 | $695.84 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 47 | $664.76 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 12 | $543.82 |
| 86141 | <1% | 16 | $473.97 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 45 | $389.23 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 34 | $368.17 |
| 82570 | <1% | 12 | $363.61 | |
| 82043 | <1% | 13 | $321.20 | |
| 87205 | <1% | 15 | $314.36 | |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 16 | $293.30 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 15 | $128.96 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 71 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 87 | $0.00 |
| A9270 | Non-covered item or service | 0% | 2,797 | $0.00 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 0% | 22 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCOHEN, LARRY (CEO)
| Provider | Location | Paid |
|---|---|---|
| Public Hospital District 3 of Pacific County | Iiwaco, WA | $3.28M |
| CRTS, INC | Bowling Green, KY | $356K |
| Public Hospital District 3 of Pacific County | Ocean Park, WA | $257K |
| Public Hospital District 3 of Pacific County | Naselle, WA | $191K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.